Keith Crandell
CIK: 0001219039
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 1, 2026BOLD
Boundless Bio, Inc.
Exercise(M)Indirect16K shares at avg. $1.03$16K - Jul 1, 2026BOLD
Boundless Bio, Inc.
Sale(S)Indirect16K shares at avg. $2.49$40K - Jun 11, 2026MASS
908 Devices Inc.
Award(A)DirectStock Option (option to buy)
6.2K shares- - Jun 11, 2026MASS
908 Devices Inc.
Award(A)DirectRestricted Stock Units
13.7K shares- - Jun 10, 2026MASS
908 Devices Inc.
Exercise(M)Direct14.1K shares- - Feb 5, 2026TWST
Twist Bioscience Corp
Award(A)Direct5.1K shares- - Jun 12, 2025MASS
908 Devices Inc.
Award(A)DirectRestricted Stock Units
14.1K shares- - Jun 12, 2025MASS
908 Devices Inc.
Award(A)DirectStock Option (option to buy)
6.5K shares- - Jun 11, 2025MASS
908 Devices Inc.
Exercise(M)Direct11.4K shares- - Feb 5, 2025TWST
Twist Bioscience Corp
Award(A)Direct4.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  BOLD Boundless Bio, Inc. | Exercise(M) | 16,000 | $1.03 | $16,480 | Indirect |
| Jul 1, 2026 | BOLD Boundless Bio, Inc. | Sale(S) | 16,000 | $2.49 | $39,840 | Indirect |
| Jun 11, 2026 |  MASS 908 Devices Inc. | Award(A) Stock Option (option to buy) | 6,209 | - | - | Direct |
| Jun 11, 2026 | MASS 908 Devices Inc. | Award(A) Restricted Stock Units | 13,656 | - | - | Direct |
| Jun 10, 2026 | MASS 908 Devices Inc. | Exercise(M) | 14,083 | - | $0 | Direct |
| Feb 5, 2026 |  TWST Twist Bioscience Corp | Award(A) | 5,095 | - | $0 | Direct |
| Jun 12, 2025 | MASS 908 Devices Inc. | Award(A) Restricted Stock Units | 14,083 | - | - | Direct |
| Jun 12, 2025 | MASS 908 Devices Inc. | Award(A) Stock Option (option to buy) | 6,516 | - | - | Direct |
| Jun 11, 2025 | MASS 908 Devices Inc. | Exercise(M) | 11,364 | - | - | Direct |
| Feb 5, 2025 | TWST Twist Bioscience Corp | Award(A) | 4,472 | - | - | Direct |
1-10 of 10 transactions
About CRANDELL KEITH
CRANDELL KEITH (SEC CIK 0001219039) files insider reports with the SEC as 10% Owner of Boundless Bio, Inc. (BOLD), Director of 908 Devices Inc. (MASS) and Director of Twist Bioscience Corp (TWST).
Signal8 holds 5 ownership filings by CRANDELL KEITH, all Form 4s, filed between Feb 7, 2025 and Jul 6, 2026. Those filings report 10 transactions, from Feb 5, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CRANDELL KEITH's filings is in CHICAGO, IL.
Recent filings by CRANDELL KEITH
- Jul 1, 2026: Option exercise of BOLD shares (Form 4, code M).
- Jul 1, 2026: Open-market sale of BOLD shares (Form 4, code S).
- Jun 11, 2026: Grants or awards of MASS derivative securities (2 lines, Form 4, code A).
- Jun 10, 2026: Option exercise of MASS shares (Form 4, code M).
- Feb 5, 2026: Grant or award of TWST shares (Form 4, code A).
Other insiders filing for Boundless Bio, Inc. (BOLD)
- TANG KEVIN, 10% Owner
- ARCH Venture Fund IX, L.P., 10% Owner
- Whiting Nancy, Director
- Lim Jonathan E, Director
- Christensen James, Director
- Lew Jennifer, Director